Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
FSD Pharma (HUGE)
NASDAQ:HUGE
FSD Pharma (HUGE) Stock Price & Analysis
355 Followers
HUGE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.13 - $1.68
Previous Close$0.14
Volume1.70M
Average Volume (3M)1.29M
Market Cap
$5.58M
Enterprise Value$2.08M
Total Cash (Recent Filing)$3.51M
Total Debt (Recent Filing)$339.20K
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Aug 09, 2024EPS Estimate
-$0.06Last Dividend Ex-Date
Nov 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding39,376,795
10 Day Avg. Volume893,947
30 Day Avg. Volume1,288,451
Standard Deviation0.21
R-Squared0.02
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.16
Forecast
1Y Price Target
$2.60Price Target Upside1608.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
FSD Pharma News
PremiumCompany Announcements
FSD Pharma Shareholders Elect Directors and Approve Resolutions
PremiumCompany Announcements
FSD Pharma Updates Shareholders on Recent ChangesPremiumCompany Announcements
FSD Pharma Amps Up Market Presence and Settles Debts
PremiumCompany Announcements
FSD Pharma Secures Multi-Million Arbitration Victory
PremiumCompany Announcements
FSD Pharma Advances MS Treatment with Clinical Trial
PremiumCompany Announcements
FSD Pharma Explores Breakthrough Dietary Supplement TechOwnership Overview
Currently, No data available
---
HUGE FAQ
What was FSD Pharma’s price range in the past 12 months?
FSD Pharma lowest stock price was $0.13 and its highest was $1.68 in the past 12 months.
What is FSD Pharma’s market cap?
Currently, no data Available
When is FSD Pharma’s upcoming earnings report date?
FSD Pharma’s upcoming earnings report date is Aug 09, 2024 which is in 16 days.
How were FSD Pharma’s earnings last quarter?
FSD Pharma released its earnings results on May 15, 2024. The company reported -$0.049 earnings per share for the quarter, the consensus estimate of -$0.049 by $0.
Is FSD Pharma overvalued?
According to Wall Street analysts FSD Pharma’s price is currently Undervalued.
Does FSD Pharma pay dividends?
FSD Pharma pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on FSD Pharma dividends here
What is FSD Pharma’s EPS estimate?
FSD Pharma’s EPS estimate is -$0.06.
How many shares outstanding does FSD Pharma have?
FSD Pharma has 40,437,595 shares outstanding.
What happened to FSD Pharma’s price movement after its last earnings report?
FSD Pharma reported an EPS of -$0.049 in its last earnings report, expectations of -$0.049. Following the earnings report the stock price went down -8.571%.
Which hedge fund is a major shareholder of FSD Pharma?
Currently, no hedge funds are holding shares in HUGE
---
FSD Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.60 (1608.28% Upside)
$2.60 (1608.28% Upside)
Insider Transactions
Sold Shares
Worth $311.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.92%
12-Months-Change
Fundamentals
Return on Equity
-61.89%
Trailing 12-Months
Asset Growth
-47.63%
Trailing 12-Months
Company Description
FSD Pharma
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.
---
HUGE Stock 12 Month Forecast
Average Price Target
$2.60
▲(1608.28% Upside)
Technical Analysis
Best Analysts Covering HUGE
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-62.00%
reiterated a buy rating 3 months ago
Copying BJ Cook, CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -62.00% per trade.
---